Skip to main content

Table 1 Inclusion and exclusion criteria

From: The diagnostic indicators of gestational diabetes mellitus from second trimester to birth: a systematic review

Criteria

Inclusion

Exclusion

Population

Pregnant women classified as having or not GDM with a specified method

Women with diabetes and other pregnancy complications such as preeclampsia or hypertension, not valid comparison, not specified diabetes type, studies in animals

Intervention

Evaluation of blood analytes, amniotic fluid analytes, annexes samples, and ultrasound assessment

Analytes collected from the 14th weeks of gestation to the time of birth and focused on GDM women

Genetic analytes (e.g. nucleotide polymorphisms), urine analytes

Comparison

Non GDM patients or different groups of GDM patients (for examples diet only, medications)

 

Outcomes

- Comparison of values between GDM patients compared to non GDM ones (measured/compared and reported)

- A total cohort of at least 30 AND/OR groups of minimum 15 patients and specified diagnostic process

 

Study design

Randomized control trial, case–control, cohort, diagnostic study

Comprehensible English language

Systematic reviews, case-reports, review articles

Quality assessment

CASP scores: at least 7/11 for case–control studies and 8/12 for diagnostic and cohort studies

 
  1. CASP Critical Appraisal Skills Programme
  2. Annexes sample Biomarkers of placenta and umbilical cord